Working… Menu
Trial record 97 of 134 for:    acne AND peroxide

Combination Treatment for Moderate to Severe Acne

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01206348
Recruitment Status : Completed
First Posted : September 21, 2010
Last Update Posted : November 30, 2011
Information provided by (Responsible Party):
Medicis Global Service Corporation

Brief Summary:
To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne

Condition or disease Intervention/treatment Phase
Acne Drug: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide Phase 4

Detailed Description:
A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 97 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Phase IV, Open-Label Study Evaluating the Use of Solodyn (Minocycline HCL Extended-Release Tablets), Ziana, and Triaz Foaming Cloths as Combination Acne Therapy Prior to Treatment With Isotretinoin
Study Start Date : September 2010
Actual Primary Completion Date : July 2011
Actual Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acne

Arm Intervention/treatment
Experimental: Open Label Combination
Solodyn, Ziana, Triaz FC
Drug: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide
Solodyn 1 tablet, Q day Ziana Gel, topical Q am Triaz FC, topical Q night

Primary Outcome Measures :
  1. Proportion of patients showing improvement from Baseline and Week 12 [ Time Frame: Week 12 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   12 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)

Exclusion Criteria:

  • pregnancy and allergies

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01206348

Layout table for location information
United States, Alabama
Birmingham, Alabama, United States
United States, California
Santa Monica, California, United States
United States, Delaware
Hockessin, Delaware, United States
United States, Massachusetts
Chestnut Hill, Massachusetts, United States
United States, Michigan
Detroit, Michigan, United States
United States, Nevada
Henderson, Nevada, United States
United States, North Carolina
High Point, North Carolina, United States
United States, Pennsylvania
Hershey, Pennsylvania, United States
United States, Tennessee
Nashville, Tennessee, United States
United States, Utah
Salt Lake City, Utah, United States
Sponsors and Collaborators
Medicis Global Service Corporation
Layout table for investigator information
Study Chair: Mary Sanstead, BSN, CCRP Medicis Global Service Corporation

Layout table for additonal information
Responsible Party: Medicis Global Service Corporation Identifier: NCT01206348     History of Changes
Other Study ID Numbers: MP-0104-28
First Posted: September 21, 2010    Key Record Dates
Last Update Posted: November 30, 2011
Last Verified: November 2011
Keywords provided by Medicis Global Service Corporation:
Additional relevant MeSH terms:
Layout table for MeSH terms
Acne Vulgaris
Benzoyl Peroxide
Acneiform Eruptions
Skin Diseases
Sebaceous Gland Diseases
Anti-Bacterial Agents
Anti-Infective Agents
Protein Synthesis Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Dermatologic Agents
Antineoplastic Agents
Keratolytic Agents